# Trial of Dapsone 5.0% Gel in the Treatment of Acne Vulgaris

> **NCT02865005** · PHASE3 · COMPLETED · sponsor: **Seegpharm S.A.** · enrollment: 2361 (actual)

## Conditions studied

- Acne Vulgaris

## Interventions

- **DRUG:** Dapsone 5.0% Gel (SEEGPharm)
- **OTHER:** Placebo
- **DRUG:** Dapsone 5.0% Gel (Allergan)

## Key facts

- **NCT ID:** NCT02865005
- **Lead sponsor:** Seegpharm S.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-02
- **Primary completion:** 2016-11
- **Final completion:** 2016-12
- **Target enrollment:** 2361 (ACTUAL)
- **Last updated:** 2016-12-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02865005

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02865005, "Trial of Dapsone 5.0% Gel in the Treatment of Acne Vulgaris". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02865005. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*